Use of Aprepitant (80 mg) for Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Laparoscopic Sleeve Gastrectomy
Innovations in Surgery and Interventional Medicine · 2024
DOI: 10.36401/isim-23-04 ↗Kurz gefasst
Fachartikel in der Zeitschrift Innovations in Surgery and Interventional Medicine, 2024. Verfasst von Mohamed Dahman und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Introduction
Postoperative nausea and vomiting (PONV) is a complication after surgery, and more significantly after bariatric surgery (up to 79%) leading to increased treatment costs associated with prolonged hospital stays. In a community hospital setting, a standard prophylactic regimen was compared with the addition of aprepitant.
Methods
A retrospective chart review of PONV among patients who underwent laparoscopic sleeve gastrectomy. Primary outcomes: efficacy of aprepitant 80 mg plus standard prophylaxis on PONV by measuring the number of antiemetics administered postoperatively to a standard prophylactic regimen.
Results
A total of 354 patients showed that the aprepitant group required significantly fewer doses in four time periods: within 1 hour of post-anesthesia care unit (PACU) admission [74 vs 97 (p = 0.049)], 12 hours [192 vs 234 (p = 0.049)], 24 hours [293 vs 426 (p < 0.001)], and total doses during admission 365 vs 581 (p < 0.001). Average length of stay (LOS) was 1.19 days for the aprepitant group and 1.33 days for the control group (p < 0.001).
Conclusion
Aprepitant significantly reduced antiemetic use postoperatively and should be considered in addition to a standard PONV prophylaxis regimen to prevent PONV in patients undergoing laparoscopic sleeve gastrectomy and to potentially reduce LOS.
Zitieren
APA
Dahman, M., Ratermann, C., & Rozzo, A. (2024). Use of Aprepitant (80 mg) for Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Laparoscopic Sleeve Gastrectomy. Innovations in Surgery and Interventional Medicine. https://doi.org/10.36401/isim-23-04
Vancouver
Dahman M, Ratermann C, Rozzo A. Use of Aprepitant (80 mg) for Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Laparoscopic Sleeve Gastrectomy. Innovations in Surgery and Interventional Medicine. 2024. doi:10.36401/isim-23-04
BibTeX
@article{Dahman2024,
author = {Dahman, Mohamed and Ratermann, Craig and Rozzo, Alexandra},
title = {Use of Aprepitant (80 mg) for Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Laparoscopic Sleeve Gastrectomy},
journal = {Innovations in Surgery and Interventional Medicine},
year = {2024},
doi = {10.36401/isim-23-04}
}
EUVIMED